Aceso Life Science Group Limited (0474.HK) HKSE

0.11

-0.009(-7.83%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap367.05M
Enterprise Value2.54B
P/E Ratio-2.09
PEG Ratio-0.04
Price/Sales Ratio4.57
Price/Book Ratio2.09
Enterprise/Revenue10.7
Enterprise/EBITDA-8.46

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-2.24
Operating Margin-0.32

Management Effectiveness

Return On Assets-0.22
Return On Equity-1.94

Income Statement

Revenue195M
Revenue/Share0.02
Gross Profit90M
EBITDA-860M
Net Income-895M
Diluted EPS-0.12

Balance Sheet

Total Cash330M
Total Cash/Share0.05
Total Debt1.21B
Total Debt/Equity3.25
Current Ratio0
Book Value Per Share0.05

Price History

52-Week Change112
52-Week High0.14
52-Week Low0.02
Moving Average 50 Days0.11
Moving Average 200 Days0.05

Statistics

Average Volume27.99M
Shares Outstanding7.15B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor7:6
Last Split DateJuly 12, 2017